Search

Search Constraints

You searched for: Author/Creator Gleixner, Karoline V.

Search Results

1. A kinase profile-adapted drug combination elicits synergistic cooperative effects on leukemic cells carrying BCR-ABL1T315I in Ph+ CML. (March 2019)

2. CD52 is a molecular target in advanced systemic mastocytosis. Issue 8 (23rd April 2014)

3. Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification. Issue 8 (16th March 2020)

4. N‐terminal pro‐brain natriuretic peptide is a prognostic marker for response to intensive chemotherapy, early death, and overall survival in acute myeloid leukemia. Issue 2 (1st January 2023)

5. Presence of viremia during febrile neutropenic episodes in patients undergoing chemotherapy for malignant neoplasms. Issue 6 (3rd May 2021)

6. Successful treatment of vaccine‐induced prothrombotic immune thrombocytopenia (VIPIT). (11th June 2021)

7. The pan‐Bcl‐2 blocker obatoclax promotes the expression of Puma, Noxa, and Bim mRNA and induces apoptosis in neoplastic mast cells. Issue 1 (19th September 2013)